GlassScriptPhysician profile
Simona E Arnautov
NPI 1003559428
$3,875.60
in general payments reported to CMS, 2019-2025
33 companies · $978 in 2025
The $978 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $540 · 2023: $1,177 · 2024: $1,180 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,236 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,236.37 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $642.65 | 2022-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $331.81 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $300.33 | 2023-2025 | |
| Cvrx, INC. | $287.12 | 2023-2024 | Barostim Neo System |
| Medtronic, INC. | $274.31 | 2023-2025 | Micra, Linq II, Venaseal |
| Astrazeneca Pharmaceuticals LP | $266.73 | 2023-2025 | Farxiga, Andexxa, Brilinta |
| Amgen INC. | $258.68 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $228.21 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $181.68 | 2022-2024 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $143.61 | 2025 | Opsumit, Uptravi |
| Scpharmaceuticals INC. | $93.27 | 2023-2025 | |
| Azurity Pharmaceuticals, INC. | $90.24 | 2023-2025 | Edarbyclor, Edarbyclor, Edarbi |
| Janssen Pharmaceuticals, INC | $90.23 | 2022-2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $79.84 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $76.64 | 2022-2025 | Nexletol |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $53.41 | 2025 | |
| Angiodynamics, INC. | $51.40 | 2022-2023 | Venacure 1470 Pro |
| Sanofi-Aventis U.S. LLC | $46.47 | 2023-2024 | |
| Kestra Medical Technology Services, INC. | $42.73 | 2025 | Assure Wcd |
| Abiomed | $42.58 | 2024 | Impella |
| Edwards Lifesciences Corporation | $32.72 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bridgebio Pharma, INC. | $32.05 | 2025 | Attruby |
| Atricure, INC. | $27.03 | 2022 | |
| Tactile Systems Technology INC | $24.11 | 2025 | Nimbl, Flexitouch Plus |
| Kiniksa Pharmaceuticals International, Plc | $23.87 | 2024 | Arcalyst |
| Novo Nordisk INC | $23.73 | 2025 | Ozempic |
| Alnylam Pharmaceuticals INC. | $23.45 | 2023 | Onpattro |
| Kiniksa Pharmaceuticals, LTD. | $21.54 | 2023 | Arcalyst |
| Amarin Pharma, INC. | $19.61 | 2022 | |
| Inari Medical, INC. | $18.85 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Baxter Healthcare | $17.97 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Zoll Circulation INC | $14.92 | 2025 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Heartflow, INC. | $13.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simona Arnautov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.